key: cord-0951711-17nywa0d
authors: Anaba, Ehiaghe L.
title: Prevalence and pattern of acute dermatological manifestations of the novel COVID‐19 infection at a COVID‐19 treatment center in Sub‐Saharan Africa
date: 2021-03-23
journal: Dermatol Ther
DOI: 10.1111/dth.14953
sha: 10e3b737f062eace77b026dd75005f40371f6a1b
doc_id: 951711
cord_uid: 17nywa0d

nan

symptoms, new onset rash or skin discoloration, duration of rash and temporal relationship with COVID-19 symptoms was used. The severity of COVID-19 was graded based on oxygen saturation (SpO 2 ) and oxygen therapy. Any patient who had an SpO 2 above 95% on room air and was not being treated with oxygen was regarded as having a moderate severity. Any patient who had an SpO 2 less than 95% on room air and required oxygen therapy was graded as severe. Data were analyzed using SPSS version 20 (SPSS Inc., Chicago). Simple means and frequencies are presented.

The mean age of the patients was 54.4 ± 14.4 years (age range of 16-88 years). The duration of COVID-19 ranged from 5 days to 4 weeks with a mean duration of 11.84 (6.11) days. The severity of COVID-19 was moderate in 57.1% (Table 1) . Seven patients had cutaneous manifestation of COVID-19 giving a prevalence of 4.2%. The cutaneous manifestations were urticaria, morbilliform rash, purpura, blister and a scaly patch. In two patients, the cutaneous manifestation started at the same time with the COVID-19 symptoms while in five patients, it started after the symptoms.

Since the advent of the novel COVID-19 virus pandemic, diverse cutaneous patterns and diseases have been attributed to COVID-19. [1] [2] [3] [4] [5] The present study documents the prevalence and cutaneous manifesta- 

Cutaneous signs in COVID-19 patients: a review

Cutaneous manifestations in COVID-19: a first perspective

Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases

SARS-CoV-2 infection presenting as a febrile rash

Cutaneous manifestations in COVID-19: family cluster of urticarial rash

A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema

Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature

Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): a prospective study from China and Italy